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Background: Fungal infection accounts for significant rates of morbidity and mortality; however, there 
is paucity of systematic data on the incidence and prevalence of human mycoses in Malaysia. Here, 
we estimated the burden of serious human fungal infections in Malaysia for the first time.
Material/methods: We found no existing data and so estimated the incidence and prevalence of 
fungal diseases based on the populations at risk. HIV data were derived from UNAIDS (2012) report 
and the 2013 WHO TB report. COPD and asthma data were derived from Lim et al (2015) and To et 
al, (2012) respectively. Pneumocystis and histoplasmosis dta were from Ratanasuwan (2005) and 
Lian (2007) respectively, and T. marneffei from Vietnam data.
Results: The population of Malaysia is ~ 30,651,000; 29% are children, and 8% female are >60 years. 
Individuals living with HIV/AIDS are 82,000 as of 2012, of whom 35,000 with CD4 counts <350 are not 
on therapy. Recurrent vaginal candidiasis (>4 episodes/year) was common (n=501,138). Oesophageal 
candidiasis (n=5,850) was the predominant fungal infection among individuals with HIV. In subjects 
with HIV/AIDS, cryptococcal memningitis was estimated in 700 and P. jirovecii pneumonitis (PCP) in 
1296, disseminated histoplasmosis in 175 and T. marneffei infection in 350 subjects. Candidemia 
(n=1,533) cases were estimated using a 5/100,000 population rate. Among the estimated 1.2 million 
adults with asthma, allergic bronchopulmonary aspergillosis (ABPA) was estimated as  in 30,062 and 
severe asthma with fungal sensitisation  in 39,682. Among 18,932 pulmonary TB survivors in 2013, 
chronic pulmonary aspergillosis was estimated in 833, and a prevalence of 2,624, perhaps 50% of the 
total. Invasive aspergillosis was estimated in 1,018 cases notably in ICU with COPD, as well as acute 
leukaemia. 
Conclusions: The present study indicates that at least 619,388 (2%) of the population is affected by a 
serious fungal infection annually. This problem is serious enough to warrant the first epidemiological 
studies of fungal disease in Malaysia.
Table : Estimated cases per year of more frequent serious fungal diseases in Malaysia
Number of infections per underlying disorder per 
year
Infection
None HIV/AI
DS
Respiratory Cancer/
Tx
ICU
Total 
burden
Rate 
/100K
Oesophageal 
candidiasis
- 5,850 - - - 5,850 19
Candidaemia - - - 1,073 460 1,533 5
Recurrent vaginal 
candidiasis (4x/year 
+)
501,138 - - - - 501,138 4,800*
ABPA - - 30,062 - - 30,062 98
SAFS - - 39,682 39,682 130
Chronic pulmonary 
aspergillosis
- - 5,249 - - 5,249 17
Invasive aspergillosis - - 184 834 1,018 3.3
Cryptococcal 
meningitis
- 700 - - - 700 2.8
Pneumocystis 
pneumonia
- 1,286 - - - 1286 4.2
Histoplasmosis 175 175 0.6
T. marneffei 
infection
350 350 1.1
Fungal keratitis 400 400 1.3
Total burden 
estimated
501,583 8,361 75,826 1,365 1,524
